Figure 3. Growth Inhibition of HRASV12 Expressing and Non-expressing Cell Lines by the Positive Control Compound Erastin (CID 11214940) Identified in Pilot Screening.

Figure 3Growth Inhibition of HRASV12 Expressing and Non-expressing Cell Lines by the Positive Control Compound Erastin (CID 11214940) Identified in Pilot Screening

Growth inhibition concentration-response curves of erastin in engineered BJ fibroblasts expressing oncogenic HRASV12 (BJeLR, DRD) or lacking HRASV12 (BJeHLT, BJeH).

From: Screen for RAS-Selective Lethal Compounds and VDAC Ligands - Probe 2

Cover of Probe Reports from the NIH Molecular Libraries Program
Probe Reports from the NIH Molecular Libraries Program [Internet].

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.